RAC1 and cardiac hypertrophy: To investigate the role of Rac1 S-palmitoylation in a mouse model of pathologic cardiac hypertrophy, we implanted osmotic minipumps to chronically infuse either saline or AngII (3 mg/kg/day) for 2 weeks.